AU2003239462A1 - HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS - Google Patents

HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS

Info

Publication number: AU2003239462A1
Authority: AU; Australia
Prior art keywords: htlv; tax; cancer cells; induced killing; null cancer
Prior art date: 2002-05-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003239462A

Other versions

AU2003239462A8 (en

Inventor

Gary Michael Kupfer

Oliver John Semmes Iv

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Virginia Patent Foundation

Original Assignee

Eastern Virginia Medical School

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-17

Filing date

2003-05-16

Publication date

2003-12-02

2003-05-16 Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School

2003-12-02 Publication of AU2003239462A8 publication Critical patent/AU2003239462A8/en

2003-12-02 Publication of AU2003239462A1 publication Critical patent/AU2003239462A1/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
- C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
- C12N2740/14041—Use of virus, viral particle or viral elements as a vector
- C12N2740/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

AU2003239462A 2002-05-17 2003-05-16 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS Abandoned AU2003239462A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38085302P	2002-05-17	2002-05-17
US60/380,853		2002-05-17
PCT/US2003/015280 WO2003097799A2 (en)	2002-05-17	2003-05-16	HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS

Publications (2)

Publication Number	Publication Date
AU2003239462A8 AU2003239462A8 (en)	2003-12-02
AU2003239462A1 true AU2003239462A1 (en)	2003-12-02

Family

ID=29550026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003239462A Abandoned AU2003239462A1 (en)	2002-05-17	2003-05-16	HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS

Country Status (5)

Country	Link
EP (1)	EP1509086A4 (en)
JP (1)	JP2005534638A (en)
AU (1)	AU2003239462A1 (en)
CA (1)	CA2486327A1 (en)
WO (1)	WO2003097799A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7425700B2 (en)	2003-05-22	2008-09-16	Stults John T	Systems and methods for discovery and analysis of markers
AU2020326698A1 (en)	2019-08-05	2022-02-24	Seer, Inc.	Systems and methods for sample preparation, data generation, and protein corona analysis

2003
- 2003-05-16 AU AU2003239462A patent/AU2003239462A1/en not_active Abandoned
- 2003-05-16 EP EP03734032A patent/EP1509086A4/en not_active Withdrawn
- 2003-05-16 CA CA002486327A patent/CA2486327A1/en not_active Abandoned
- 2003-05-16 WO PCT/US2003/015280 patent/WO2003097799A2/en not_active Application Discontinuation
- 2003-05-16 JP JP2004506458A patent/JP2005534638A/en active Pending

Also Published As

Publication number	Publication date
CA2486327A1 (en)	2003-11-27
AU2003239462A8 (en)	2003-12-02
EP1509086A4 (en)	2005-08-10
WO2003097799A3 (en)	2004-04-01
WO2003097799A2 (en)	2003-11-27
EP1509086A2 (en)	2005-03-02
JP2005534638A (en)	2005-11-17

Legal Events

Date	Code	Title	Description
2005-02-03	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Publication	Publication Date	Title
AU2003232851A1 (en)	2004-01-06	Fungicidal combinations of active substances
AU2003290587A1 (en)	2004-06-07	Folding directional antenna
AU2003240581A1 (en)	2004-01-19	Ventricular connector
AU2003237686A1 (en)	2003-12-12	Rna interference mediating small rna molecules
AU2164101A (en)	2001-06-25	Fungicidal combinations of active substances
AU5289000A (en)	2000-12-12	Reliable datagram
AU2307400A (en)	2000-08-25	Downhole tractor
AU2001267839A1 (en)	2002-03-13	Sulfonium salt compound
AUPS054702A0 (en)	2002-03-07	Cancer therapy
AU2002215772A1 (en)	2002-06-24	Implantable neurostimulator
AU2003266161A1 (en)	2004-04-30	High concentration topical insecticide
AU6847300A (en)	2001-03-05	Exhaust volume
AUPP938799A0 (en)	1999-04-15	Electrodes
AU6593600A (en)	2001-03-19	Drugs inhibiting cell death
AU2282501A (en)	2001-07-09	Autonomous omnidirectional driller
AU3479000A (en)	2000-08-25	Dermatological patch
AU2002258740A1 (en)	2002-10-21	Methods and compounds for decreasing cell toxicity or death
AU2001272242A1 (en)	2002-01-02	Portable incubator
AU2003239462A1 (en)	2003-12-02	HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS
AU2003280813A1 (en)	2004-06-23	Active antenna
AU7957000A (en)	2001-05-08	Cyclooxygenase-2 expression inhibitors
AU2003212826A1 (en)	2003-09-02	Cancer genes
AU2003206989A1 (en)	2003-09-16	Multifrequency antenna
AU2002218744A1 (en)	2002-01-21	Bax fragment induced tumor cell death
AU1618901A (en)	2001-05-30	Treatment of rosacea